Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Processa Pharmaceuticals Inc (NQ: PCSA ) 1.730 -0.080 (-4.42%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Processa Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 Next > 12 Health Care Stocks Moving In Friday's Pre-Market Session February 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session February 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session February 03, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday February 03, 2023 Good morning! It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday! Via InvestorPlace Processa Pharma's Investigational Candidate Improves Gastroparesis-Associated Clinical Symptoms December 14, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session February 02, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday January 30, 2023 On Monday, 13 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 25, 2023 On Wednesday, 22 companies hit new 52-week lows. Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Biotech Showcase January 04, 2023 Via Investor Brand Network Exposures Product Safety Stocks That Hit 52-Week Lows On Friday December 30, 2022 Friday's session saw 75 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday December 29, 2022 On Thursday, 116 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday December 22, 2022 Thursday's session saw 329 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 21, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 21, 2022 Via Benzinga Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session December 14, 2022 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) PCS12852 Demonstrates Clinically Meaningful Improvements in Gastroparesis Symptoms December 14, 2022 Via Investor Brand Network Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial December 14, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update November 08, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) PCS12852 Demonstrates Improved Gastric Emptying in Phase 2A Trial November 08, 2022 Via Investor Brand Network Exposures Product Safety PCS12852 Improves Gastric Emptying in Gastroparesis Patients November 08, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Earnings Preview: Processa Pharmaceuticals November 07, 2022 Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q3 2022 Results, Provide Pipeline Update November 02, 2022 Via Investor Brand Network Exposures Product Safety Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST November 02, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Reports Successful Results from NGC Phase 2B Trial November 01, 2022 Via Investor Brand Network Exposures Product Safety Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial November 01, 2022 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday September 29, 2022 Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Shares Update on Clinical Programs Enrollment September 15, 2022 Via Investor Brand Network Exposures COVID-19 InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at Upcoming Global Investment Conference September 07, 2022 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Names New Key Board Appointments August 16, 2022 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Q2 2022 Results, Corporate Updates August 12, 2022 Via Investor Brand Network Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.